{"id":49852,"date":"2022-10-20T13:05:40","date_gmt":"2022-10-20T11:05:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/"},"modified":"2022-10-20T13:05:40","modified_gmt":"2022-10-20T11:05:40","slug":"torus-biosystems-previews-orbit-pcr-at-idweek","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/","title":{"rendered":"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122"},"content":{"rendered":"
\n

\nqPCR redefined to advance research and innovation<\/i>\n<\/p>\n

MEDFORD, Mass.–(BUSINESS WIRE)–Torus Biosystems<\/a> (\u201cTorus\u201d or the \u201cCompany\u201d) today announced that it would be introducing Orbit PCR\u2122 <\/sup>for Research Use Only (RUO) applications at ID<\/b>Week\u2122 in Washington, DC. Using Orbit PCR, researchers can identify 300+ nucleic acid target sequences per sample within 30 minutes. Orbit PCR is possible due to the innovative integration of three technologies including free-flow qPCR, a wash-free pre-quenched microarray, and toehold probes.\n<\/p>\n

<\/a><\/p>\n

\n\u201cFor biomedical and research laboratories that are studying disease causing pathogens, our Orbit PCR offers a tool for enabling pioneering research,\u201d said Shawn Marcell, President & CEO, Torus Biosystems. \u201cThe SNP discerning, high multiplex capability coupled with fast turnaround time represents a game changing advance in the field of infectious disease and antimicrobial resistance research.\u201d\n<\/p>\n

\nThe Company plans to make Orbit PCR commercially available for Research Use Only in Q1 2023.\n<\/p>\n

\nAbout Torus Biosystems<\/b>\n<\/p>\n

\nTorus Biosystems<\/a>, a spinout from the Harvard Wyss Institute for Biologically Inspired Engineering, is on a mission to transform patient lives by delivering breakthrough innovations in infectious disease research and diagnostics. The Company is currently developing syndromic testing solutions based on the integration of novel technologies, including qPCR and microarray technologies, that enable rapid, quantitative, and highly multiplexed detection of microbial pathogens and resistance genes that ultimately lead to improved patient outcomes. Learn more about how Torus can help clinicians deliver better patient care, combat antibiotic resistance, and promote antimicrobial stewardship by visiting the website at www.torus.bio<\/a> and connecting on social media @Twitter<\/a> and @LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
Brian Thomson
\n
brian.thomson@torus.bio<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

qPCR redefined to advance research and innovation MEDFORD, Mass.–(BUSINESS WIRE)–Torus Biosystems (\u201cTorus\u201d or the \u201cCompany\u201d) today announced that it would be introducing Orbit PCR\u2122 for Research Use Only (RUO) applications at IDWeek\u2122 in Washington, DC. Using Orbit PCR, researchers can identify 300+ nucleic acid target sequences per sample within 30 minutes. Orbit PCR is possible … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49852","6":"format-standard","7":"category-industry"},"yoast_head":"\nTorus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"qPCR redefined to advance research and innovation MEDFORD, Mass.–(BUSINESS WIRE)–Torus Biosystems (\u201cTorus\u201d or the \u201cCompany\u201d) today announced that it would be introducing Orbit PCR\u2122 for Research Use Only (RUO) applications at IDWeek\u2122 in Washington, DC. Using Orbit PCR, researchers can identify 300+ nucleic acid target sequences per sample within 30 minutes. Orbit PCR is possible ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-20T11:05:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221020005061\/en\/1606482\/21\/Torus_ID_cmyk.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122\",\"datePublished\":\"2022-10-20T11:05:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005061\\\/en\\\/1606482\\\/21\\\/Torus_ID_cmyk.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/\",\"name\":\"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005061\\\/en\\\/1606482\\\/21\\\/Torus_ID_cmyk.jpg\",\"datePublished\":\"2022-10-20T11:05:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005061\\\/en\\\/1606482\\\/21\\\/Torus_ID_cmyk.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005061\\\/en\\\/1606482\\\/21\\\/Torus_ID_cmyk.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/torus-biosystems-previews-orbit-pcr-at-idweek\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/","og_locale":"en_US","og_type":"article","og_title":"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122 - Pharma Trend","og_description":"qPCR redefined to advance research and innovation MEDFORD, Mass.–(BUSINESS WIRE)–Torus Biosystems (\u201cTorus\u201d or the \u201cCompany\u201d) today announced that it would be introducing Orbit PCR\u2122 for Research Use Only (RUO) applications at IDWeek\u2122 in Washington, DC. Using Orbit PCR, researchers can identify 300+ nucleic acid target sequences per sample within 30 minutes. Orbit PCR is possible ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-20T11:05:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221020005061\/en\/1606482\/21\/Torus_ID_cmyk.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122","datePublished":"2022-10-20T11:05:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/"},"wordCount":269,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221020005061\/en\/1606482\/21\/Torus_ID_cmyk.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/","url":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/","name":"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221020005061\/en\/1606482\/21\/Torus_ID_cmyk.jpg","datePublished":"2022-10-20T11:05:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221020005061\/en\/1606482\/21\/Torus_ID_cmyk.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221020005061\/en\/1606482\/21\/Torus_ID_cmyk.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49852"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49852\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}